These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7833220

  • 1. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
    Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM.
    Br J Clin Pharmacol; 1994 Oct; 38(4):317-21. PubMed ID: 7833220
    [Abstract] [Full Text] [Related]

  • 2. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Witherow FN, Helmy A, Webb DJ, Fox KA, Newby DE.
    Circulation; 2001 Oct 30; 104(18):2177-81. PubMed ID: 11684627
    [Abstract] [Full Text] [Related]

  • 3. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM.
    J Cardiovasc Pharmacol; 1993 Oct 30; 22(4):579-84. PubMed ID: 7505360
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
    Legat FJ, Griesbacher T, Lembeck F.
    Br J Pharmacol; 1994 Jun 30; 112(2):453-60. PubMed ID: 7915609
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.
    Hornig B, Kohler C, Drexler H.
    Circulation; 1997 Mar 04; 95(5):1115-8. PubMed ID: 9054837
    [Abstract] [Full Text] [Related]

  • 13. Effect of early blockade of bradykinin B2-receptors on the blood pressure phenotype of normotensive and spontaneously hypertensive rats.
    Emanueli C, Madeddu P.
    Pharmacol Res; 1997 Jun 04; 35(6):522-6. PubMed ID: 9361315
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
    Labinjoh C, Newby DE, Pellegrini MP, Johnston NR, Boon NA, Webb DJ.
    J Am Coll Cardiol; 2001 Nov 01; 38(5):1402-8. PubMed ID: 11691515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR, Jaffa AA, Mayfield RK, Ploth DW.
    Hypertension; 1996 Feb 01; 27(2):235-44. PubMed ID: 8567046
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP, Oyama TT, Thompson MM, Anderson S.
    Diabetes; 1997 Jan 01; 46(1):107-12. PubMed ID: 8971089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.